NCT04441060

Brief Summary

The aims of this study are developments of distress intervention and a suicidal risk scale for the patients with chronic medical illness or physical disabilities. To do these things, four times of interview \& completion of self-report scale will be done, and newly developed distress intervention will be simulated to subject group and control group.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
15

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Apr 2019

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

April 29, 2019

Completed
12 months until next milestone

First Submitted

Initial submission to the registry

April 23, 2020

Completed
2 months until next milestone

First Posted

Study publicly available on registry

June 22, 2020

Completed
2.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 30, 2022

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

July 30, 2022

Completed
Last Updated

January 9, 2024

Status Verified

May 1, 2022

Enrollment Period

3.3 years

First QC Date

April 23, 2020

Last Update Submit

January 7, 2024

Conditions

Outcome Measures

Primary Outcomes (14)

  • Quality of life: World Health Organization's quality of life instrument -short version (WHOQOL-BREF)

    Quality of life was assessed three times using the World Health Organization's quality of life instrument - short version (WHOQOL-BREF); before and after the intervention, and 1 month later after the intervention is finished. The amount of quality of life change will be one of the primary outcomes.

    baseline, within a week after the end of the full course of intervention, and 1 month later after the intervention is finished

  • Stress: Perceived Stress Scale (PSS-10)

    Stress was assessed three times using Perceived Stress Scale (PSS-10); before and after the intervention, and 1 month later after the intervention is finished. The amount of Stress change will be one of the primary outcomes.

    baseline, within a week after the end of the full course of intervention, and 1 month later after the intervention is finished

  • Resilience: Connor-Davidson Resilience Scale (CDRS)

    Resilience was assessed three times using Connor-Davidson Resilience Scale (CDRS); before and after the intervention, and 1 month later after the intervention is finished. The amount of resilience change will be one of the primary outcomes.

    baseline, within a week after the end of the full course of intervention, and 1 month later after the intervention is finished

  • Self-esteem: Rosenberg Self-Esteem Scale

    Self-esteem was assessed three times using Rosenberg Self-Esteem Scale; before and after the intervention, and 1 month later after the intervention is finished. The amount of Self-esteem change will be one of the primary outcomes.

    baseline, within a week after the end of the full course of intervention, and 1 month later after the intervention is finished

  • Acceptance of disability: Acceptance of Disability Scale

    Acceptance of disability was assessed three times using Acceptance of Disability Scale; before and after the intervention, and 1 month later after the intervention is finished. The amount of acceptance of disability change will be one of the primary outcomes.

    baseline, within a week after the end of the full course of intervention, and 1 month later after the intervention is finished

  • Social participation: Participation Scale

    Social participation was assessed three times using Participation Scale; before and after the intervention, and 1 month later after the intervention is finished. The amount of Social participation change will be one of the primary outcomes.

    baseline, within a week after the end of the full course of intervention, and 1 month later after the intervention is finished

  • Pain: Pain belief & Perception inventory (PBPI)

    Pain was assessed three times using Pain belief \& Perception inventory (PBPI); before and after the intervention, and 1 month later after the intervention is finished. The amount of pain change will be one of the primary outcomes.

    baseline, within a week after the end of the full course of intervention, and 1 month later after the intervention is finished

  • Insomnia: Insomnia Severity Index (ISI)

    Insomnia was assessed three times using Insomnia Severity Index (ISI); before and after the intervention, and 1 month later after the intervention is finished. The amount of Insomnia change will be one of the primary outcomes.

    baseline, within a week after the end of the full course of intervention, and 1 month later after the intervention is finished

  • Fatigue: FACIT-Fatigue

    Fatigue was assessed three times using FACIT-Fatigue; before and after the intervention, and 1 month later after the intervention is finished. The amount of fatigue change will be one of the primary outcomes.

    baseline, within a week after the end of the full course of intervention, and 1 month later after the intervention is finished

  • Depression, Anxiety: Hospital Anxiety and Depression Scale

    Depression and anxiety was assessed three times using Hospital Anxiety and Depression Scale; before and after the intervention, and 1 month later after the intervention is finished. The amount of depression and anxiety change will be one of the primary outcomes. The 14-item Hospital Anxiety and Depression Scale comprises two subscales assessing anxiety and depression. Participants were asked to rate each item on a 4- point Likert scale (0-3); subscale scores ranged from 0 to 21. A cutoff score of 8 was applied to define clinical level of anxiety and depression.

    baseline, within a week after the end of the full course of intervention, and 1 month later after the intervention is finished

  • Attention: Digit Span Test

    Attention was assessed three times using the Digit Span Test; before and after the intervention, and 1 month later after the intervention is finished. The Digit Span test is a neuropsychological test in most common use for measuring attention-concentration and working memory. The amount of Digit Span Test result (percentile score) change will be one of the primary outcomes.

    baseline, within a week after the end of the full course of intervention, and 1 month later after the intervention is finished

  • Attention: Trail Making Test

    Attention was assessed three times using the Trail Making Test; before and after the intervention, and 1 month later after the intervention is finished. The Trail Making Test is a widely used neuropsychological measure that is known as a test of psychomotor speed, attention, sequencing, mental flexibility. The amount of Trail Making Test result (time to complete test) change will be one of the primary outcomes.

    baseline, within a week after the end of the full course of intervention, and 1 month later after the intervention is finished

  • Attention: Stoop Color-Word Test

    Attention was assessed three times using the Stoop Color-Word Test; before and after the intervention, and 1 month later after the intervention is finished. The Stroop color word test is useful to examines the frontal lobe function of selective attention and inhibition. The amount of Stoop Color-Word Test results (Time taken to perform, number performed correctly, number of errors) change will be one of the primary outcomes.

    baseline, within a week after the end of the full course of intervention, and 1 month later after the intervention is finished

  • Suicide risk : Korea-Suicide Risk Scale (the name can be changed later)

    Suicide risk scale will be developed and compared with other known tools. The scale has no definite name yet, but it can be called as Korea-Suicide Risk Scale for now. A score will be reported on a scale, the higher score, the severe the suicidal risk. About 90 questions are developed for the scale, and out of them, meaningful questions will be selected through large-scale interview \& comparison with other scales about suicide during the study. We are not sure how many questions are selected by now, so the minimum or maximum score cannot be decided so far. Though, the questions have 4 point scale from 0 to 3.

    through study completion, an average of 1 year

Study Arms (2)

distress intervention subject group

EXPERIMENTAL

Distress intervention program will be developed, and applied to the subject group, and they will be assessed before and after the intervention program with several tools.

Other: Distress intervention (CBT & Mindfulness-based program)

distress intervention control group

NO INTERVENTION

No intervention will be applied to the control group. They will be assessed before and after the intervention program with same tools with subject group.

Interventions

Distress intervention is not fully developed yet, but we are working on the development of distress intervention based on CBT \& Mindfulness-based program.

distress intervention subject group

Eligibility Criteria

Age19 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients with chronic illness or physical disabilities (Heart failure, Chronic kidney disease, Stroke patients)

You may not qualify if:

  • Patients who have other severe illness such as cancer, severe memory impairment or intellectual disabilities and others

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Seoul National University Hospital

Seoul, 16801, South Korea

Location

MeSH Terms

Conditions

Chronic Disease

Condition Hierarchy (Ancestors)

Disease AttributesPathologic ProcessesPathological Conditions, Signs and Symptoms

Study Officials

  • Bong-Jin Hahm, M.D., Ph.D.

    Seoul National University Hospital

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

April 23, 2020

First Posted

June 22, 2020

Study Start

April 29, 2019

Primary Completion

July 30, 2022

Study Completion

July 30, 2022

Last Updated

January 9, 2024

Record last verified: 2022-05

Data Sharing

IPD Sharing
Will not share

Locations